Pain medicine case reports · 2024
Sclerotherapy for Management of Intrathecal Pump Seroma Formation: A Case Series.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Allbritten Grant, Bigham Joshua, Harned Michael E, Mallard Christopher J
Аннотация
BACKGROUND: Intrathecal drug delivery systems (ITDDS) are an option for the treatment of chronic pain syndromes or spasticity that are refractory to other conservative measures; however, they are not without complications. Seroma formation is one of the possible complications following implantation of an ITDDS.
CASE REPORT: We present 3 separate cases of patients with recalcitrant seroma formation at their IT pump sites that were successfully treated with doxycycline pleurodesis.
CONCLUSIONS: Pump site seroma formation is a possible complication following implantation of an ITDDS. Typically, these are self-limiting, but if not addressed can result in complications which include pain, infection, and difficulty filling. We propose a case series of 3 patients who suffered from recurrent seroma formation following ITDDS implantation that were successfully treated with doxycycline-based sclerotherapy.
CASE REPORT: We present 3 separate cases of patients with recalcitrant seroma formation at their IT pump sites that were successfully treated with doxycycline pleurodesis.
CONCLUSIONS: Pump site seroma formation is a possible complication following implantation of an ITDDS. Typically, these are self-limiting, but if not addressed can result in complications which include pain, infection, and difficulty filling. We propose a case series of 3 patients who suffered from recurrent seroma formation following ITDDS implantation that were successfully treated with doxycycline-based sclerotherapy.